Johnson & Johnson will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12.
NEW BRUNSWICK, N.J., May 29, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, at the Terranea Resort in Rancho Palos Verdes, California. Tom Cavanaugh, President, Oncology, Janssen Pharmaceuticals and Scott White, President, Immunology will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately two hours after the live webcast.
CONTACT: Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M); Cristal Downing, (732) 524-3283, (908) 616-8833 (M); Investor Contacts: Joseph J. Wolk, (732) 524-1142, Lesley Fishman, (732) 524-3922
View original content with multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-goldman-sachs-39th-annual-global-healthcare-conference-300655743.html
SOURCE Johnson & Johnson
